AstraZeneca pulls out of bid to hold Covid-19 vaccine trials in Philippines; virus cases almost reaching 450,000


People wearing face masks and face shields shop for Christmas lanterns at a store in Las Pinas City, Metro Manila, Philippines. The Covid-19 cases on Saturday (Dec 12) was almost reaching 450,000, announced the DOH of the Philippines. - Reuters

MANILA, Dec 12 (Xinhua): AstraZeneca, the Britain-based drug maker, has withdrawn its application to conduct Covid-19 vaccine clinical trials in the Philippines, the country's Food and Drug Administration (FDA) has announced.

"They (AstraZeneca) said they have enough data already," Enrique Domingo, the FDA director general, said in a text message to Xinhua, explaining the reason AstraZeneca cited for withdrawing trials application.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

6.6-magnitude earthquake hits off Taiwan, reports USGS
Asean News Headlines at 10pm on Saturday (Dec 27, 2025)
Police in India's capital arrest hundreds in security crackdown before before the New Year festivities
Suspected explosives found on Nilai bomb maker at time of arrest
A 40-year-old woman charged over 15kg methamphetamine seizure at Sydney Airport
The Philippines is ready to shape the future of regular tourism as the Asean chairmanship duty nears
Sunday polls bring hopes to Myanmar, junta says on election eve
Year-end clampdown on crime in Singapore sees over 1,700 people investigated, more than 500 arrested
Thailand's worst incident - The SAO building collapse: causes, accountability and the impact of 2025’s defining tragedy
Indonesian rescuers search for Spanish family after boat sinks near Komodo Island

Others Also Read